Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A survey of hepatitis C treatment clinical practice patterns using the newly approved protease inhibitors.

Journal of clinical gastroenterology - 1 Oct 2013

Chen Emerson Y, Lee William M, Hynan Linda S, Singal Amit G

Abstract excerpt

GOALS: To describe current hepatitis C virus (HCV) treatment practices in the United States and identify physician characteristics associated with the use of first generation direct-acting antivirals (DAAs). BACKGROUND: HCV treatment practice patterns have not been assessed after the introduction of DAA, which are now considered standard of care for most HCV genotype 1 patients. STUDY: We sampled nationally...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Health Care Surveys

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C

Share to Liver Cirrhosis

Share to Logistic Models

Share to Multivariate Analysis

Share to Practice Patterns, Physicians'

Share to Protease Inhibitors

Source

Open in PubMed Open full text

Identifiers

PMID: 23470640
DOI: 10.1097/MCG.0b013e31828a37c0
PMCID: PMC3732573

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A survey of hepatitis C treatment clinical practice patterns using the newly approved protease inhibitors.PMID 23470640Read ↗

Uptake of and Factors Associated With Direct-acting Antiviral Therapy Among Patients in the Chronic Hepatitis Cohort Study, 2014 to 2015.Semantic proximity Read ↗

Diagnosis and Management of Hepatitis C Infection in Primary Care Settings.Semantic proximity Read ↗

Outcomes of treatment with direct-acting antivirals for infection with hepatitis C virus genotypes 1-4 in an ambulatory care setting.Semantic proximity Read ↗

Hepatitis C Management Simplification From Test to Cure: A Framework for Primary Care Providers.Semantic proximity Read ↗

Prevalence of drug-drug interactions with pangenotypic direct-acting antivirals for hepatitis C and real-world care management in the United States: a retrospective observational study.Semantic proximity Read ↗

Real-world use of elbasvir-grazoprevir in patients with chronic hepatitis C: retrospective analyses from the TRIO network.Semantic proximity Read ↗

Genotype 1 hepatitis C virus and the pharmacist's role in treatment.Semantic proximity Read ↗

HCV Council--critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscape.Semantic proximity Read ↗

Provisional guidance on the use of hepatitis C virus protease inhibitors for treatment of hepatitis C in HIV-infected persons.Semantic proximity Read ↗

United States Provider Experiences with Telemedicine for Hepatitis C Treatment: A Nationwide SurveySemantic proximity Read ↗

Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study.Semantic proximity Read ↗

Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.